Vumerity Euroopa Liit - rumeenia - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Zometa solutie perfuzabila 4 mg/100 ml Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zometa solutie perfuzabila 4 mg/100 ml

novartis pharma ag - acid zoledronicum - solutie perfuzabila - 4 mg/100 ml

Avelox comprimate filmate 400 mg Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

avelox comprimate filmate 400 mg

bayer ag - moxifloxacinum - comprimate filmate - 400 mg

Avelox solutie perfuzabila 400 mg/250 ml Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

avelox solutie perfuzabila 400 mg/250 ml

bayer ag - moxifloxacinum - solutie perfuzabila - 400 mg/250 ml

Bemfola Euroopa Liit - rumeenia - EMA (European Medicines Agency)

bemfola

gedeon richter plc. - folitropină alfa - anovulația - hormoni sexuali și modulatori ai sistemului genital, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. În studiile clinice la acești pacienți au fost definite printr-o concentrație plasmatică de lh endogen < 1. 2 ui / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

MICOFENOLAT MOFETIL STADA 250 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

micofenolat mofetil stada 250 mg

apotex nederland b.v. - olanda - mycophenolatum mofetilum - caps. - 250 mg - imunosupresoare imunosupresoare selective

MICOFENOLAT MOFETIL STADA 500 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

micofenolat mofetil stada 500 mg

apotex nederland b.v. - olanda - mycophenolatum mofetilum - compr. film. - 500 mg - imunosupresoare imunosupresoare selective

AVELOX® 400 mg/250 ml Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

avelox® 400 mg/250 ml

bayer pharma ag - moxifloxacinum - sol. perf. - 400mg/250ml - chinolone antibacteriene fluorochinolone

AVELOX® 400 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

avelox® 400 mg

bayer pharma ag - moxifloxacinum - compr. film. - 400mg - chinolone antibacteriene fluorochinolone

Zometa 4 mg/100 ml soluţie perfuzabilă Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zometa 4 mg/100 ml soluţie perfuzabilă

novartis pharma ag - acid zoledronicum - soluţie perfuzabilă - 4 mg/100 ml